bazedoxifene has been researched along with Obesity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Beyl, RA; Burant, CF; Hayes, EK; Lovre, D; Marlatt, KL; Mauvais-Jarvis, F; Ravussin, E; Tate, CR | 1 |
Ahmed, M; Barrera, J; Chambliss, KL; McDonald, JG; Mineo, C; Shaul, PW; Tanigaki, K; Thompson, B | 1 |
Lovre, D; Mauvais-Jarvis, F; Xu, B | 1 |
1 review(s) available for bazedoxifene and Obesity
Article | Year |
---|---|
The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
Topics: Aging; Animals; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Humans; Indoles; Insulin Resistance; Models, Biological; Obesity; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2017 |
1 trial(s) available for bazedoxifene and Obesity
Article | Year |
---|---|
Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Estrogens, Conjugated (USP); Female; Glucose; Humans; Indoles; Lipid Metabolism; Middle Aged; Obesity; Pilot Projects; Postmenopause | 2020 |
1 other study(ies) available for bazedoxifene and Obesity
Article | Year |
---|---|
Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Topics: Abdominal Fat; Adiposity; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Fatty Liver; Female; Indoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Ovariectomy; Selective Estrogen Receptor Modulators; Uterus | 2014 |